6CM
AGN

683 Capital Management’s Allergan plc AGN Stock Holding History

683 Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-62,000
Closed -$12.7M – 163
2017
Q3 		$12.7M Sell
62,000
-20,000
-24% -$4.65M 1.34% 22
2017
Q2 		$19.9M Buy
82,000
+5,000
+6% +$1.17M 2.94% 7
2017
Q1 		$18.4M Sell
77,000
-9,000
-10% -$2.1M 2.86% 10
2016
Q4 		$18.1M Buy
86,000
+41,000
+91% +$8.49M 1.29% 23
2016
Q3 		$10.4M Buy
45,000
+5,000
+13% +$1.22M 1.1% 29
2016
Q2 		$9.24M Buy
+40,000
New +$9.22M 1.47% 26
2016
Q1 		– Sell
-30,000
Closed -$9.38M – 94
2015
Q4 		$9.38M Buy
+30,000
New +$8.93M 1.28% 24

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

683 Capital Management's AGN Position: Q4 2017 in Review

683 Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 62,000 shares — an estimated $12.7M sold.

683 Capital Management first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $19.9M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • 683 Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • 683 Capital Management sold 62,000 Allergan plc shares in Q4 2017, an estimated $12.7M.
  • 683 Capital Management first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • 683 Capital Management's Allergan plc position peaked at $19.9M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on 683 Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.